Avalon Investment & Advisory Ani Pharmaceuticals Inc Transaction History

Avalon Investment & Advisory

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$52.95 - $71.34 $2.55 Million - $3.44 Million	-48,153 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$56.38 - $68.08 $227,775 - $275,043	4,040 Added 9.16%	48,153 $3.22 Million
Q1 2018 Jun 26, 2018	SELL	$56.98 - $72.41 $341 - $434	-6 Reduced 0.01%	44,113 $2.57 Million
Q1 2018 May 15, 2018	BUY	$56.98 - $72.41 $2.51 Million - $3.19 Million	44,119 New	44,119 $2.57 Million

211

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

Stay updated on Avalon Investment & Advisory with notifications on news.